{
  "https://www.natera.com/oncology": "d23dcab14cf3f37d9638a51bcf069cae7261a646ece7998d3ce0b7889b809ae6",
  "https://www.natera.com/company/news": "a8b66df10acd729ade886afa94e5e430f4e87b790eede995f78b8df3e71b8386",
  "https://guardanthealth.com/products/tests-for-cancer-screening": "33e88c47f94e40f36d797a8324667689312e4cf4b54726c8eb3c5bb804338880",
  "https://guardanthealth.com/products/tests-for-patients-with-early-and-advanced-stage-cancer": "fa759628ef01a7255b374a3d34eb012998ab1d3724b79b464fcccf4d4e791c5a",
  "https://guardanthealth.com/newsroom/press-releases": "4a255d876e6bb8259945254cf608a00955a8b991a7699c538d576c3e8ba085aa",
  "https://www.foundationmedicine.com/genomic-testing/foundation-one-cdx": "8a79a20216e5f86be0622adc5a1feda328e3b0eb4076b1d6302c69a2cfb9598d",
  "https://www.foundationmedicine.com/test/foundationone-liquid-cdx": "8104f26789cd25ee1fc03bedcec35376321ee9d50e54a2ea0480802b56f79100",
  "https://www.foundationmedicine.com/press-releases": "3bbb47ab1eafdc3b9a9535607a3e1887fecac1d8f9dc7aad6014d5df486adc3c",
  "https://www.tempus.com/oncology/genomic-profiling": "65afe2256ef591b777af6e9e184bc99ec2c26409c4a941c0f1431a5075bed143",
  "https://www.tempus.com/news": "3320bd88dfaafa41a63ea147300b5bd34b3c6428d985268706bc4cb20aedc614",
  "https://www.carislifesciences.com/products-and-services/molecular-profiling": "42d603b72301731bcaa0781adeffbc13f7df4e7ca4fd22fb01166e25a706a384",
  "https://www.carislifesciences.com/news-and-events/news": "0aa7bc44330fc84852a6c5d9f54c489d2701acd61b6c8d64d5ce74cae2592dfd",
  "https://www.grail.com/galleri": "881bbd1a139b982232360c8dba737ef21771097e49b9ff380d2c02d10e6108bc",
  "https://www.grail.com/press-releases": "e1c332383c6638a86293793f9b49f020d53699083f9140c3d0d8563defc500ba"
}